Biomea Fusion, Inc. (BMEA)
BMEA Stock Price Chart
Explore Biomea Fusion, Inc. interactive price chart. Choose custom timeframes to analyze BMEA price movements and trends.
BMEA Company Profile
Discover essential business fundamentals and corporate details for Biomea Fusion, Inc. (BMEA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
16 Apr 2021
Employees
79.00
Website
https://biomeafusion.comCEO
Michael J. Hitchcock
Description
Biomea Fusion, Inc. is a biopharmaceutical firm dedicated to discovering and developing innovative covalent small molecule therapies. These treatments are specifically designed for individuals suffering from genetically defined cancers and various metabolic ailments. The company's primary drug candidate, BMF-219, is a potent and selective covalent inhibitor of menin, engineered for oral administration. Menin plays a crucial role as a transcriptional regulator in the abnormal signaling pathways found across numerous cancer types. Established in 2017, Biomea Fusion's operations are headquartered in Redwood City, California.
BMEA Financial Timeline
Browse a chronological timeline of Biomea Fusion, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is -$0.21.
Earnings released on 11 May 2026
EPS came in at -$0.17 surpassing the estimated -$0.24 by +29.17%.
Earnings released on 24 Mar 2026
EPS came in at -$0.64 falling short of the estimated -$0.25 by -156.00%.
Earnings released on 4 Nov 2025
EPS came in at -$0.27 falling short of the estimated -$0.26 by -3.85%.
Earnings released on 5 Aug 2025
EPS came in at -$0.51 surpassing the estimated -$0.59 by +13.56%.
Earnings released on 5 May 2025
EPS came in at -$0.80 surpassing the estimated -$0.84 by +4.76%.
Earnings released on 31 Mar 2025
EPS came in at -$0.81 surpassing the estimated -$1.00 by +19.00%, while revenue for the quarter reached $1.22m .
Earnings released on 29 Oct 2024
EPS came in at -$0.91 surpassing the estimated -$1.05 by +13.33%.
Earnings released on 31 Jul 2024
EPS came in at -$1.03 matching the estimated -$1.03.
Earnings released on 2 May 2024
EPS came in at -$1.09 falling short of the estimated -$1.02 by -6.86%.
Earnings released on 1 Apr 2024
EPS came in at -$0.98 falling short of the estimated -$0.85 by -15.29%, while revenue for the quarter reached $6.14m .
Earnings released on 30 Oct 2023
EPS came in at -$0.80 surpassing the estimated -$0.83 by +3.61%.
Earnings released on 31 Jul 2023
EPS came in at -$0.70 surpassing the estimated -$0.86 by +18.60%.
Earnings released on 2 May 2023
EPS came in at -$0.98 falling short of the estimated -$0.80 by -22.50%.
Earnings released on 28 Mar 2023
EPS came in at -$0.86 falling short of the estimated -$0.81 by -6.17%.
Earnings released on 7 Nov 2022
EPS came in at -$0.78 falling short of the estimated -$0.65 by -20.00%.
Earnings released on 1 Aug 2022
EPS came in at -$0.59 surpassing the estimated -$0.60 by +1.67%.
Earnings released on 16 May 2022
EPS came in at -$0.56 falling short of the estimated -$0.53 by -5.66%.
Earnings released on 28 Feb 2022
EPS came in at -$0.51 falling short of the estimated -$0.45 by -13.33%.
Earnings released on 3 Nov 2021
EPS came in at -$0.43 falling short of the estimated -$0.40 by -7.50%.
Earnings released on 11 Aug 2021
EPS came in at -$0.33 falling short of the estimated -$0.22 by -50.00%.
BMEA Stock Performance
Access detailed BMEA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
